RecruitingNCT07149740

Data Gathering for A10900


Sponsor

Optos, PLC

Enrollment

180 participants

Start Date

Jun 26, 2025

Study Type

OBSERVATIONAL

Conditions

Summary

The objective of this study is to gather Optical Coherence Tomography (OCT) data on normal and diseased eyes


Eligibility

Min Age: 22 Years

Plain Language Summary

Simplified for easier understanding

This study is collecting imaging data from patients with retinal (eye) diseases to develop and improve the A10900 device, a tool designed to examine the back of the eye. The goal is to gather high-quality eye images to help refine this technology. **You may be eligible if...** - You are 22 years old or older - You have been diagnosed with a retinal condition such as macular degeneration, diabetic macular edema, diabetic retinopathy, macular hole, epiretinal membrane, or similar - Your vision in the study eye is 20/400 or better - You understand and are willing to sign the consent form **You may NOT be eligible if...** - You are unable to tolerate the imaging procedure - You do not have a retinal condition that fits the study's requirements Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEOCT

A10900 is an optical coherence tomography device


Locations(4)

Ketchum Health

Anaheim, California, United States

Eye Disease Consultants, LLC

West Hartford, Connecticut, United States

Eye Care and Laser Surgery of Newton Wellselley

Wellesley Hills, Massachusetts, United States

Charles Retina Institute

Germantown, Tennessee, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07149740


Related Trials